Comoros vs Iceland: HIV/AIDS deaths averted by antiretroviral therapy
Comoros
7.94 deaths
in 2024
Iceland
13.85 deaths
in 2024
Comoros rank
154th
Iceland rank
152nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Comoros
- Iceland
How they compare
Iceland currently reports 13.85 deaths against 7.94 deaths in Comoros, a difference of 5.91 deaths.
That makes Iceland's figure about 1.7 times Comoros's.
Across all 35 years both countries report, Iceland has been ahead every year.
Comoros ranks 154th and Iceland ranks 152nd of 157 countries.
Iceland has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Comoros | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0.6236 deaths | 0.6236 deaths | Iceland |
| 2000s | 0 deaths | 7.56 deaths | 7.56 deaths | Iceland |
| 2010s | 4.45 deaths | 10.17 deaths | 5.72 deaths | Iceland |
| 2020s | 7.51 deaths | 12.92 deaths | 5.41 deaths | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Comoros or Iceland?
- Iceland, at 13.85 deaths against 7.94 deaths in Comoros as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Comoros and Iceland?
- 5.91 deaths, with Iceland ahead.
- How many years of comparable data are there for Comoros and Iceland?
- 35 years are reported by both, from 1990 to 2024.
- How do Comoros and Iceland rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Comoros ranks 154th and Iceland ranks 152nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.